NRG ONCOLOGY/RTOG 0921: A PHASE II STUDY OF POSTOPERATIVE INTENSITY MODULATED RADIATION THERAPY (IMRT) WITH CONCURRENT CISPLATIN AND BEVACIZUMAB FOLLOWED BY CARBOPLATIN AND PACLITAXEL FOR PATIENTS WITH ENDOMETRIAL CANCER

PURPOSE: To assess acute and late adverse events (AEs), overall survival (OS), pelvic failure (PF), regional failure, distant failure, and disease-free survival (DFS) in a prospective phase II clinical trial of bevacizumab (Bev) and pelvic intensity modulated radiation therapy (IMRT) with chemothera...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer
Hlavní autoři: Viswanathan, Akila N., Moughan, Jennifer, Miller, Brigitte E., Xiao, Ying, Jhingran, Anuja, Portelance, Lorraine, Bosch, Walter, Matulonis, Ursula, Horowitz, Neil, Mannel, Robert S., Souhami, Luis, Erickson, Beth, Winter, Kathryn, Small, William, Gaffney, David
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4685031/
https://ncbi.nlm.nih.gov/pubmed/25847373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29337
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky